Yunyun Duan1, Yaou Liu1, and Jiazheng Wang2
1Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 2Philips (China) Investment Co., Ltd, Beijing, China
Synopsis
A major barrier of clinical application of
3D T1 sequence is the long acquisition time. Compressed SENSE (CS-SENSE) was introduced
into the clinical routine and showed reduced scan time without reduced image quality.
However, automatically quantitative assessment of brain structure has not been
certificated up to date. This study evaluated the different acceleration
factors of CS-SENSE or SENSE of a 3D brain T1 sequence with qualitative and quantitative
measurements in health volunteers and patients, in order to assess the
feasibility of 3D brain structural imaging acceleration.
Abstract
Introduction: A major barrier of clinical application of 3D T1 sequence is the
long acquisition time. Compressed SENSE (CS-SENSE) [1] was introduced into the
clinical routine and showed reduced scan time without reduced image quality [2-6],
especially with 3D sequences. However, automatically quantitative assessment
such as brain volume, which is critical in the 3DT1, has not been certificated
up to date. The aim of the study is to identify the optimal acceleration factor
for 3D T1 images for clinical and research. We evaluated the image quality and
cost efficiency of different acceleration factors of CS-SENSE (3, 4.5 and 6) or
SENSE (3 and 4.5) of a 3D brain T1 sequences (tested with qualitative and
quantitative measurements) in HC, MS and AD patients, compared to the standard reference
3D sequence without any accelerated technique.
Methods: This single-center prospective study was approved by the
institutional review board. Written informed consent was obtained from all
participants. 53 subjects were recruited including 33 healthy controls (HCs),
10 multiple sclerosis (MS) patients and 10 Alzheimer's disease (AD) patients. The
scan was repeated one month lateras in five HCs. A conventional 3D T1-TFE
sequence with 1mm isotropic resolution (reference sequence, RS) and accelerated
sequences with CS-SENSE (acceleration factor of 3, 4.5, 6, abbreviated as CS3,
CS4.5,CS6) and SENSE (acceleration factor of 3, 4.5, abbreviated as SE3, SE4.5)
were acquired for all participants on a 3.0-Testla
MR system (Ingenia CX , Philips Healthcare, Best, the Netherlands) (Table1). Qualitative measures
including visual assessment of the overall image quality, visual signal noise
ratio (SNR), image contrast, lesion boundary sharpness, motion artifact and
image artifacts were assessed by
two blinded to the MR technique independently, and then in consensus. Quantitative image quality metrics [7] and intraclass correlation
coefficients (ICC) between RS and the different accelerated sequences were
performed using VBM analysis based on CAT12. The group comparisons between HC
and AD or MS were performed by VBM analysis.
Results: For the visual assessment in HCs, AD and MS patients, there were no
significant difference in any metrics between RS and CS3 (with 65% scan time
reduction). For the overall image quality, sequence CS4.5 showed no significant
difference compared to RS. Visual SNR is visually reduced from CS4.5 (p<0.05),
CS6 and SE3, 4.5 sequence (p<0.01). For lesion or gray-white matter boundary
sharpness, CS 6 and SE 4.5 showed reduced quality (p<0.01). All the
accelerated sequences showed good gray-white matter contrast. Motion artifacts
mildly increased with no significance in the RS for the long scan time. For the
image artifacts, only SE4.5 showed significant increased image artifacts
(p<0.01). MS and AD patients group showed consistent results with HCs .
Quantitative metrics, including signal-to-noise
ratio (SNR) , coefficient of joint variation (CJV) , contrast-to-noise ratio (CNR)
and entropy-focus criterion (EFC) and FBER, showed significant
decrease trend from the RS to SE4.5(p<0.001, FDR corrected)(Fig.2). There’s no
significant difference of the SNR in the grey matter between different accelerated
scan and RS. The ICC values of each accelerated scan and reference one were
high (Fig.3). For the group comparisons, AD or MS patients and HCs were compared
using the same acceleration factor. Each protocol can catch the most significant
group differences (Fig.4).
Discussion
For the visual assessment, CS3 showed
optimal image quality with 65% scan time reduction. Visual image quality was
mainly affected by the decreased SNR (CS4.5, CS6, SE3, SE4.5), unsharp lesion
boundary (CS6, SE4.5) and somewhat image artifacts (SE4.5).
The ICC values of different acceleration
factor with RS are really high enough. However, the ICC values slightly
decreased with no significance in the regions of cerebellum,
subcortical regions, periventricular area, and the temporal pole. Group difference showed higher test-retest properties using VBM. Each
protocol can catch the most significant group differences.
Conclusion: CS-SENSE with factor 3 can accelerates the 3D brain T1 (65% time
reduction) with preserved visual image quality for radiological diagnosis. CS-SENCE
with factor 3, 4.5 (65, 72% time reduction) can quantify brain volume measurements
without compromising image quality.Acknowledgements
The authors thank the patients as well as healthy volunteers for participating in this study, and members of the neurology team for various supports.References
References
1. Geerts-Ossevoort L, deWeerdt E,
Duijndam A, van Ijperen G, Peeters H, Doneva M, Nijenhuis M, Huang A.
Compressed SENSE. Speed done right. Every time. Philips® healthcare,
Netherlands. Available via https://philipsproductcontent.blob.core.windows.net/ assets/20180109/619119731f2a42c4acd4a863008a46c7.pdf. Accessed 16
May 2018.
2. Fushimi Y,
Fujimoto K, Okada T, et al. Compressed
sensing 3-dimensional time of flight magnetic resonance angiography for
cerebral aneurysms: optimization and evaluation. Invest Radiol. 2016;
51:228–235.
3.Toledano-Massiah S, Sayadi A, de
Boer R, et al. Accuracy of the compressed sensing accelerated 3D-FLAIR sequence
for the detection of MS plaques at 3T. AJNR Am J Neuroradiol. 2018; 39:454–8.
4. Vranic JE,
Cross NM, Wang Y, et al. Compressed
sensing-sensitivity encoding (CS-SENSE) accelerated brain imaging: reduced scan
time without reduced image quality. AJNR Am J Neuroradiol. 2019;40:92–8.
5. Cho SJ, Choi YJ, Chung SR, et al. High-resolution MRI using compressed sensing-sensitivity
encoding (CS-SENSE) for patients with suspected neurovascular compression
syndrome: comparison with the conventional SENSE parallel acquisition
technique. Clin Radiol.
2019; 74(10):817.e9-817.
6. Eichinger P, Hock A, Schön S, et
al. Acceleration of double inversion recovery sequences in multiple sclerosis
with compressed sensing. Invest Radiol. 2019;54:319–24.
7. Dietrich O, Raya JG, Reeder SB, et
al. Measurement of signal-to-noise ratios in MR images: influence of
multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson
Imaging. 2007; 26(2):375-85.